APA

Gunnarsdottir S., Elfarra A. A., . (20040930). Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Gunnarsdottir Sjofn, Elfarra Adnan A, . 20040930. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Gunnarsdottir S., Elfarra A. A., . (20040930). Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Gunnarsdottir Sjofn, Elfarra Adnan A, . Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen. : Drug metabolism and disposition: the biological fate of chemicals. 20040930.